RT3
Product Overview
Retatrutide is a synthetic 39-amino acid peptide that acts as a triple agonist at the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCG) receptors. Its structure is based on the GIP peptide backbone and contains a C20 fatty diacid moiety that facilitates albumin binding, significantly extending its stability in research models.
This compound is intended for in vitro and in vivo laboratory research only, specifically for the study of multi-receptor nutrient-stimulated hormone signaling.
Research Applications
Triple Agonism Dynamics: Investigation of the synergistic effects of simultaneous GLP-1, GIP, and Glucagon receptor activation.
Glucagon Receptor Signaling: Study of the peptide's unique influence on thermogenesis and energy expenditure pathways via the glucagon receptor.
Metabolic Rate Analysis: Researching the impact of multi-incretin mimetics on metabolic homeostasis in animal models.
Pharmacokinetics: Analysis of the C20 fatty acid side chain’s role in extending the half-life and potency of synthetic peptides.
SOLD FOR RESEARCH PURPOSES ONLY
BAC Water Sold Separately
Syringes Not Included
Peptides Sold in Powdered Form
